Previous 10 | Next 10 |
As America has become increasingly progressive in its drug policy, psychedelics have turned from relatively obscure drugs enjoyed by a niche community to potentially game-changing mental-health treatments. Studies on hallucinogenic drugs such as psilocybin (magic mushrooms), MDMA and ayahuasca ...
A recent psychedelic study has indicated that hallucinogens such as psilocybin may be able to unlock the critical “learning period ” when mammals are more susceptible to their outside environment. This is a period of brain development when mammals can engage with their surroundings...
Previous research has discovered that psilocybin can effectively treat substance-use disorders. Now, a new study has provided new insights into how psilocybin-assisted therapy works for individuals who are addicted to alcohol. For their study, scientists at UC San Francisco, NYU and Fluence...
Psychedelics are currently experiencing a renaissance that could leave them at the top of the psychiatric industry. Over the past couple of years, research has shown that natural and synthetic psychedelics show potential to treat symptoms of various mental health conditions. Although treatmen...
2023-06-05 08:50:32 ET Forza X1 ( FRZA ) +133% . Timber Pharmaceuticals ( TMBR ) +92% Announces FDA Grant of CARC Waiver for TMB-001 Chijet Motor Company ( CJET ) +55% . CIRCOR International ( CIR ) +50% to be bought by KKR in $1.6B deal. ...
SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a current focus on breast cancer, today announces the appointment of Greg...
NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in upcoming June Investor Conferences. Details of th...
A recent study has indicated that a nonhallucinogenic form of LSD may be able to treat mood disorders. LSD is one of several psychedelics that have recently gained attention from the scientific community as potential treatments for mental health conditions. Initial psychedelic studies have pr...
2023-05-25 06:07:22 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips When it comes to investing, penny stocks often evoke a sense of intrigue and opportunity. These low-priced securities, typically traded under $5 per share, can potentially deliver substanti...
Last year, the Stanley Brothers signed a partnership between a professional sports league and a hemp/marijuana brand, becoming the first to do so. Prior to this, the company’s CBD products, including Charlotte’s Web, had been gaining popularity in Colorado, especially after a sur...
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Alcohol use disorder is a disorder characterized by an inability to stop or control one’s drinking despite adverse health, occupational or social consequences. Conventional treatments include medication, behavioral therapy, and support groups. Even with these treatments, however, many ind...
Psychedelics such as DMT, LSD and psilocybin have demonstrated promise in the treatment of affective symptoms of a range of disorders. These drugs work by inducing an altered state of consciousness , which includes intensified perceptions and emotions, which have been associated with therapeutic...